These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 39071464)

  • 1. Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer.
    Chen JY; Li JD; He RQ; Huang ZG; Chen G; Zou W
    World J Clin Oncol; 2024 Jul; 15(7):867-894. PubMed ID: 39071464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes.
    Vishnubalaji R; Alajez NM
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel prognostic genes of triple-negative breast cancer using meta-analysis and weighted gene co-expressed network analysis.
    Cao W; Jiang Y; Ji X; Guan X; Lin Q; Ma L
    Ann Transl Med; 2021 Feb; 9(3):205. PubMed ID: 33708832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating linalool as a potential drug for breast cancer treatment based on machine learning and molecular docking.
    Zhang Q; Chen D
    Drug Dev Res; 2024 Jun; 85(4):e22223. PubMed ID: 38879780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research trends on nanomaterials in triple negative breast cancer (TNBC): a bibliometric analysis from 2010 to 2024.
    Liang H; Yin G; Feng D; Chen H; Liu X; Li J
    Drug Deliv Transl Res; 2024 Sep; ():. PubMed ID: 39242466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of PGK1 Promotes Sensitivity to Paclitaxel Treatment by Upregulating XAF1-Mediated Apoptosis in Triple-Negative Breast Cancer.
    Sun S; Wu H; Wu X; You Z; Jiang Y; Liang X; Chen Z; Zhang Y; Wei W; Jiang Y; Chen Y; Song Y; Pang D
    Front Oncol; 2021; 11():535230. PubMed ID: 33747900
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylation of PGK1 at lysine 323 promotes glycolysis, cell proliferation, and metastasis in luminal A breast cancer cells.
    Gao X; Pan T; Gao Y; Zhu W; Liu L; Duan W; Han C; Feng B; Yan W; Song Q; Liu Y; Yue L
    BMC Cancer; 2024 Aug; 24(1):1054. PubMed ID: 39192221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis.
    Chen DL; Cai JH; Wang CCN
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
    Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
    Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping Intellectual Structures and Research Hotspots of Triple Negative Breast Cancer: A Bibliometric Analysis.
    Hao KJ; Jia X; Dai WT; Huo ZM; Zhang HQ; Liu JW; Wang XB
    Front Oncol; 2021; 11():689553. PubMed ID: 35047380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization.
    Lin Y; Wang S; Yang Q
    Discov Oncol; 2024 Apr; 15(1):117. PubMed ID: 38609711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGK1 is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinoma.
    Yi J; Luo X; Huang W; Yang W; Qi Y; He J; Xie H
    Oncol Lett; 2024 Mar; 27(3):109. PubMed ID: 38304170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.
    Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
    Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis.
    Liu Q; Song X; Liu Z; Yu Z
    Technol Cancer Res Treat; 2021; 20():15330338211019506. PubMed ID: 34184566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
    Yuan Q; Zheng L; Liao Y; Wu G
    World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
    Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
    Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patients.
    Peng W; Tang W; Li JD; He RQ; Luo JY; Chen ZX; Zeng JH; Hu XH; Zhong JC; Li Y; Ma FC; Xie TY; Huang SN; Ge LY
    PeerJ; 2022; 10():e13708. PubMed ID: 35846880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.